Tumor Regression Grade as a Predictor of Adjuvant Therapy Benefits in Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Therapy.
Saved in:
| Title: | Tumor Regression Grade as a Predictor of Adjuvant Therapy Benefits in Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Therapy. |
|---|---|
| Authors: | Huang, Yizhou1,2,3,4 (AUTHOR), Chen, Maohui1,2,3,4 (AUTHOR), Wei, Yuanpu1,2,3,4 (AUTHOR), Cai, Bingqiang5 (AUTHOR), Zhang, Yongcong6 (AUTHOR), Lin, Chuanquan1,2,3,4 (AUTHOR), Zhang, Shuliang1,2,3,4 (AUTHOR), Zeng, Taidui1,2,3,4 (AUTHOR), Chen, Chun1,2,3,4 (AUTHOR) chenchun0209@fjmu.edu.cn, Zheng, Bin1,2,3,4 (AUTHOR) lacustrian@163.com |
| Source: | Cancer Medicine. Sep2025, Vol. 14 Issue 18, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.71166 |
